Tarek Hammoud - 11 Jul 2023 Form 4 Insider Report for Enfusion, Inc.

Reporting relationship: 10%+ Owner
Issuer ticker: N/A
Reported as of: 11 Jul 2023
Net transaction value: -$10,700,000
SEC form: 4
Accepted by SEC: 13 Jul 2023, 07:00:07 UTC
Prior SEC filing: 28 Mar 2023
Source filing: View source filing
Reporting owner signature: /s/ Tarek Hammoud

Filing notes and source

Key filing fact

Tarek Hammoud filed Form 4 for Enfusion, Inc. on 13 Jul 2023.

Key facts

This page summarizes Tarek Hammoud's Form 4 filing for Enfusion, Inc..
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 13 Jul 2023, 07:00.

Change

Previous filing in this sequence was filed on 28 Mar 2023.
Current net transaction value: -$10,700,000.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ENFN transaction

Class A Common Stock

Sale

Transaction value: $10,700,000
Shares: -1,000,000
Change %: -100%
Price: $10.70
Shares after: 386
Date: 11 Jul 2023
Ownership: See footnote
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Tarek Hammoud is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 1 footnote

Footnote F1

These securities are held by LRA Ventures, LLC. Tarek Hammoud is the sole manager of LRA Ventures, LLC, an estate planning vehicle. Mr. Hammoud may be deemed to have dispositive power over the securities held by LRA Ventures, LLC. Mr. Hammoud disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.